The DOI matches its Crossref record.
Association of Tumor Necrosis Factor α Gene Promoter Polymorphism with the Presence of Chronic Obstructive Pulmonary Disease
Abstract
Tumor necrosis factor alpha (TNF-alpha), a potent proinflammatory cytokine, may be involved in the development of chronic obstructive pulmonary disease (COPD). The production of TNF-alpha is elevated in the airways of these patients. A polymorphism at position -308 of the TNF-alpha gene promoter (TNF-alpha-308*1/2) is known to be associated with alteration of TNF-alpha secretion in vitro. In this study we examined the differences in TNF-alpha-308*1/2 allele frequency to investigate the association of this polymorphism with the presence of smoking-related COPD. TNF-alpha-308*1/2 allele frequency in 106 patients (73 men and 33 women) was compared with 110 asymptomatic smoker/ex-smoker control subjects matched for sex and age and population control subjects consisting of 129 blood donors. Genotype was analyzed by the polymerase chain reaction-restriction fragment length polymorphism technique on genomic DNA isolated from peripheral blood lymphocytes. TNF-alpha-308*1/2 allele frequencies were significantly different among the groups: 0.835/0.165 in patients with COPD, 0.918/0.082 in smoker/ex-smoker control subjects, and 0.922/0.078 in population control subjects. These results indicate that TNF-alpha-308*1/2 alleles are significantly associated with the presence of smoking-related COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease
Rennard, S. I., Fogarty, C., Kelsen, S., Long, W., Ramsdell, J., Allison, J., Mahler, D., Saadeh, C., Siler, T., Snell, P., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-995oc · Cited by 439
Definition, epidemiology and natural history of COPD
Viegi, G., Pistelli, F., Sherrill, D. L., Maio, S., Baldacci, S., & Carrozzi, L. (2007) · European Respiratory Journal · doi:10.1183/09031936.00082507 · Cited by 430
Churg, A., Dai, J., Tai, H., Xie, C., & Wright, J. L. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200202-097oc · Cited by 330
Air pollutants, oxidative stress and human health
Yang, W., & Omaye, S. T. (2009) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2008.10.005 · Cited by 326
Association between Glycemic State and Lung Function: The Framingham Heart Study
Walter, R. E., Beiser, A., Givelber, R. J., O'Connor, G. T., & Gottlieb, D. J. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2203022 · Cited by 254
Metadata
- Authors
- SAKAO, S., TATSUMI, K., IGARI, H., SHINO, Y., SHIRASAWA, H., KURIYAMA, T., & Association of Non-University-Affiliated Pulmonary Specialist Physicians of Chiba University School of Medicine
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-02-01
- Volume
- 163
- Issue
- 2
- Pages
- 420-422
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2074067866
- Cited by
- 170
- References
- 0
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of Tumor Necrosis Factor α Gene Promoter Polymorphism with the Presence of Chronic Obstructive Pulmonary Disease. https://app.cochat.ai/papers/10.1164/ajrccm.163.2.2006031
- The paper
- SAKAO, S., TATSUMI, K., IGARI, H., SHINO, Y., SHIRASAWA, H., KURIYAMA, T., & Association of Non-University-Affiliated Pulmonary Specialist Physicians of Chiba University School of Medicine. (2001). Association of Tumor Necrosis Factor α Gene Promoter Polymorphism with the Presence of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/ajrccm.163.2.2006031
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.